Hemogenyx Pharmaceuticals Plc (HOPHF)
OTCMKTS · Delayed Price · Currency is USD
0.0400
-1.2000 (-96.77%)
Jun 12, 2025, 8:00 PM EDT

Hemogenyx Pharmaceuticals Market Cap

Hemogenyx Pharmaceuticals has a market cap or net worth of $10.75 million as of June 18, 2025. Its market cap has decreased by -57.45% in one year.

Market Cap
10.75M
Enterprise Value
14.01M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04

Market Cap Chart

Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has decreased from 13.93M to 10.75M, a decrease of -22.82%. That is a compound annual growth rate of -3.31%.

History

DateMarket Cap% Change
Jun 17, 202510.68M-39.89%
Dec 31, 202417.77M-48.41%
Dec 29, 202334.44M120.18%
Dec 30, 202215.64M-37.12%
Dec 31, 202124.87M-56.46%
Dec 31, 202057.13M512.38%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Endo, Inc. 1.60B
Elite Pharmaceuticals 790.52M
Veradigm 747.25M
Nika Pharmaceuticals 708.22M
Tian'an Technology Group 637.25M
CytoDyn 437.04M
Glass House Brands 398.13M
Northwest Biotherapeutics 388.59M
Market Cap Rankings